Published in Neurology on January 25, 2005
The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol (2011) 8.15
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA (2009) 5.75
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ (2005) 5.34
Epidemiology of Alzheimer disease. Nat Rev Neurol (2011) 4.13
Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults. JAMA Neurol (2015) 4.00
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ (2010) 3.98
Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2008) 3.87
Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease. JAMA Neurol (2015) 3.58
The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol (2009) 3.13
Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study. JAMA Neurol (2014) 3.04
Predicting risk of dementia in older adults: The late-life dementia risk index. Neurology (2009) 2.92
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci (2009) 2.86
The protocols for the 10/66 dementia research group population-based research programme. BMC Public Health (2007) 2.54
Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag (2008) 2.13
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology (2007) 1.97
Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology (2011) 1.92
Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol (2014) 1.86
Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study. Hypertension (2010) 1.84
Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective. Eur J Pharmacol (2008) 1.82
Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II study. Eur Heart J (2011) 1.79
Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.78
Blood pressure and brain injury in older adults: findings from a community-based autopsy study. J Am Geriatr Soc (2009) 1.76
Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study. J Neurol Neurosurg Psychiatry (2009) 1.74
The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology (2010) 1.64
Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia (2007) 1.59
Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord (2009) 1.58
Mediterranean diet and late-life cognitive impairment: a taste of benefit. JAMA (2009) 1.55
Adiposity, type 2 diabetes, and Alzheimer's disease. J Alzheimers Dis (2009) 1.53
Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry (2012) 1.53
Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography. Eur J Nucl Med Mol Imaging (2014) 1.49
Midlife stroke risk and cognitive decline: a 10-year follow-up of the Whitehall II cohort study. Alzheimers Dement (2012) 1.45
Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores. Neurology (2013) 1.44
History of alcohol use disorders and risk of severe cognitive impairment: a 19-year prospective cohort study. Am J Geriatr Psychiatry (2014) 1.43
Mild cognitive impairment and dementia: the importance of modifiable risk factors. Dtsch Arztebl Int (2011) 1.43
Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol (2011) 1.42
Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. Neurology (2008) 1.41
Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health (2014) 1.38
Amylin deposition in the brain: A second amyloid in Alzheimer disease? Ann Neurol (2013) 1.35
Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol (2010) 1.32
Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis (2012) 1.28
Early adult to midlife cardiovascular risk factors and cognitive function. Circulation (2014) 1.28
The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiol Aging (2010) 1.25
Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis (2010) 1.22
The association between midlife cardiorespiratory fitness levels and later-life dementia: a cohort study. Ann Intern Med (2013) 1.21
Promoting successful cognitive aging: a comprehensive review. J Alzheimers Dis (2010) 1.19
Heart failure and cognitive impairment: challenges and opportunities. Clin Interv Aging (2007) 1.18
Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch Neurol (2011) 1.17
Coronary risk correlates with cerebral amyloid deposition. Neurobiol Aging (2011) 1.17
Decreased C-reactive protein levels in Alzheimer disease. J Geriatr Psychiatry Neurol (2009) 1.15
Macro- and microstructural magnetic resonance imaging indices associated with diabetes among community-dwelling older adults. Diabetes Care (2012) 1.14
Association of diabetes with amnestic and nonamnestic mild cognitive impairment. Alzheimers Dement (2013) 1.13
The effects of cardiovascular risk factors on cognitive compromise. Dialogues Clin Neurosci (2009) 1.13
Hypertension increases the probability of Alzheimer's disease and of mild cognitive impairment in an Arab community in northern Israel. Neuroepidemiology (2009) 1.12
Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol (2013) 1.10
Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology (2014) 1.10
Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals. PLoS One (2012) 1.10
Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia. Curr Psychiatry Rev (2009) 1.09
Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies. Menopause (2013) 1.08
Diabetes, related conditions, and dementia. J Neurol Sci (2010) 1.08
Cholesterol: its regulation and role in central nervous system disorders. Cholesterol (2012) 1.08
Risk factors for dementia after critical illness in elderly Medicare beneficiaries. Crit Care (2012) 1.07
Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies. J Diabetes Investig (2013) 1.07
The effects of cholesterol on learning and memory. Neurosci Biobehav Rev (2010) 1.05
Effects of hypertension and hypercholesterolemia on cognitive functioning in patients with alzheimer disease. Alzheimer Dis Assoc Disord (2008) 1.05
Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol (2014) 1.05
Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican Americans. Diabetes Care (2013) 1.04
Dietary fat composition and dementia risk. Neurobiol Aging (2014) 1.01
Blood pressure and cognition: factors that may account for their inconsistent association. Epidemiology (2013) 1.01
The cross-sectional relationship between body mass index, waist-hip ratio, and cognitive performance in postmenopausal women enrolled in the Women's Health Initiative. J Am Geriatr Soc (2010) 1.01
Diabetes is associated with increased rate of cognitive decline in questionably demented elderly. Dement Geriatr Cogn Disord (2010) 1.01
Cardiovascular risk factors and future risk of Alzheimer's disease. BMC Med (2014) 1.00
Cardiovascular health and cognitive function: the Maine-Syracuse Longitudinal Study. PLoS One (2014) 0.99
Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study. PLoS Med (2015) 0.97
Mixed cerebrovascular disease and the future of stroke prevention. Transl Stroke Res (2012) 0.97
Invited commentary: Albuminuria and microvascular disease of the brain--a shared pathophysiology. Am J Epidemiol (2010) 0.96
Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions. Neuroimage (2008) 0.96
Blood pressure and dementia - a comprehensive review. Ther Adv Neurol Disord (2009) 0.95
Interactive effects of vascular risk burden and advanced age on cerebral blood flow. Front Aging Neurosci (2014) 0.95
Elevated serum C-reactive protein relates to increased cerebral myoinositol levels in middle-aged adults. Cardiovasc Psychiatry Neurol (2012) 0.94
Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage. Psychol Aging (2013) 0.94
Perimenopause and cognition. Obstet Gynecol Clin North Am (2011) 0.94
Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease. J Alzheimers Dis (2010) 0.93
Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Exp Mol Med (2015) 0.93
Metabolic syndrome and cognitive decline among the oldest old in Okinawa: in search of a mechanism. The KOCOA Project. J Gerontol A Biol Sci Med Sci (2011) 0.93
Cardiovascular disease risk models and longitudinal changes in cognition: a systematic review. PLoS One (2014) 0.93
Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment. Clin Interv Aging (2015) 0.93
Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease. Alzheimers Dement (2014) 0.92
Severe psychiatric disorders in mid-life and risk of dementia in late- life (age 65-84 years): a population based case-control study. Curr Alzheimer Res (2014) 0.91
Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia. BMJ Open (2013) 0.91
Hypertension, brain damage and cognitive decline. Curr Hypertens Rep (2013) 0.91
Indicators of childhood quality of education in relation to cognitive function in older adulthood. J Gerontol A Biol Sci Med Sci (2012) 0.90
Depressive symptoms, chronic diseases, and physical disabilities as predictors of cognitive functioning trajectories in older Americans. J Am Geriatr Soc (2010) 0.90
Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy. Epilepsia (2007) 0.90
Blood pressure and cognition among older adults: a meta-analysis. Arch Clin Neuropsychol (2013) 0.90
Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis. J Neurochem (2014) 0.90
Higher incidence of mild cognitive impairment in familial hypercholesterolemia. Am J Med (2010) 0.89
Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders. J Neuroimmune Pharmacol (2009) 0.89
Association between Visit-to-Visit Glucose Variability and Cognitive Function in Aged Type 2 Diabetic Patients: A Cross-Sectional Study. PLoS One (2015) 0.89
Mental health in the aged: prevalence, covariates and related neuroendocrine, cardiovascular and inflammatory factors of successful aging. BMC Med Res Methodol (2010) 0.88
Body adiposity in later life and the incidence of dementia: the health in men study. PLoS One (2011) 0.88
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med (2013) 8.76
Racial discrimination and blood pressure: the CARDIA Study of young black and white adults. Am J Public Health (1996) 7.99
Central obesity and increased risk of dementia more than three decades later. Neurology (2008) 6.03
Should the Babinski sign be part of the routine neurologic examination? Neurology (2005) 5.57
Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 5.12
Short-term prognosis after emergency department diagnosis of TIA. JAMA (2000) 5.00
Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes (1996) 4.20
The beautiful and ethereal neurological exam: an appeal for research. Ann Neurol (2011) 4.10
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study. Am J Public Health (1990) 3.82
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke (2005) 3.74
Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology (2007) 3.71
Risk of stroke in children: ethnic and gender disparities. Neurology (2003) 3.47
Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA (2000) 3.36
The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. Ann Epidemiol (1995) 3.24
Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology (2012) 3.20
Race/ethnic differences in AD survival in US Alzheimer's Disease Centers. Neurology (2007) 3.18
Global variation in the relative burden of stroke and ischemic heart disease. Circulation (2011) 3.02
Glycemic control and heart failure among adult patients with diabetes. Circulation (2001) 2.99
Stroke in users of low-dose oral contraceptives. N Engl J Med (1996) 2.98
Predicting risk of dementia in older adults: The late-life dementia risk index. Neurology (2009) 2.92
Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med (2000) 2.81
Racial differences in amounts of visceral adipose tissue in young adults: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Am J Clin Nutr (1999) 2.79
Financial anatomy of neuroscience research. Ann Neurol (2006) 2.71
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Excess gains in weight and waist circumference associated with childbearing: The Coronary Artery Risk Development in Young Adults Study (CARDIA). Int J Obes Relat Metab Disord (2004) 2.65
Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet (1999) 2.59
Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med (1999) 2.57
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
NIH disease funding levels and burden of disease. PLoS One (2011) 2.56
Cigarette smoking behavior is strongly related to educational status: the CARDIA study. Prev Med (1990) 2.47
Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke (2004) 2.42
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation (2005) 2.38
Prevalence and health implications of anti-gay discrimination: a study of black and white women and men in the CARDIA cohort. Coronary Artery Risk Development in Young Adults. Int J Health Serv (1997) 2.30
Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics (2007) 2.29
Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke (2003) 2.28
Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke (2007) 2.26
Occupational exposures and the risk of COPD: dusty trades revisited. Thorax (2008) 2.20
Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol (2006) 2.17
DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study. Neurology (2003) 2.14
Communication and decision-making in seriously ill patients: findings of the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc (2000) 2.12
Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology (2005) 2.10
Influence of physician specialty on outcomes after acute ischemic stroke. J Hosp Med (2008) 2.07
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. Circulation (2008) 2.05
Getting youth in the game: can we accelerate training for clinician-scientists? Ann Neurol (2010) 2.04
A multivariate analysis of risk factors for preeclampsia. JAMA (1991) 2.03
Marijuana use and medically attended injury events. Ann Emerg Med (1998) 2.01
Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive. Stroke (2013) 2.01
Recent trauma and acute infection as risk factors for childhood arterial ischemic stroke. Ann Neurol (2012) 1.94
The association between sleep duration and obesity in older adults. Int J Obes (Lond) (2008) 1.89
Moyamoya disease in Washington State and California. Neurology (2005) 1.88
Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. Stroke (2008) 1.88
Atrophy rates of entorhinal cortex in AD and normal aging. Neurology (2003) 1.88
Intracranial atherosclerotic disease: an update. Ann Neurol (2009) 1.86
Thirty-year projections for deaths from ischemic stroke in the United States. Stroke (2003) 1.86
Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke (2011) 1.84
Declining stroke rates in Californian children with sickle cell disease. Blood (2004) 1.83
Executive function, memory, and gait speed decline in well-functioning older adults. J Gerontol A Biol Sci Med Sci (2010) 1.80
Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke (2002) 1.80
Racial discrimination and skin color in the CARDIA study: implications for public health research. Coronary Artery Risk Development in Young Adults. Am J Public Health (1998) 1.79
Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke (2003) 1.78
Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke (2005) 1.78
Association of hostility with coronary artery calcification in young adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. JAMA (2000) 1.74
Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke (2004) 1.74
Change and secular trends in physical activity patterns in young adults: a seven-year longitudinal follow-up in the Coronary Artery Risk Development in Young Adults Study (CARDIA). Am J Epidemiol (1996) 1.73
Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc (1999) 1.73
Predictors and outcomes of intraprocedural rupture in patients treated for ruptured intracranial aneurysms: the CARAT study. Stroke (2008) 1.72
A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke. Stroke (2011) 1.72
Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke (2010) 1.71
Translational research for a new administration: what sort of change to believe in? Ann Neurol (2008) 1.71
Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial. Bull World Health Organ (2009) 1.70
Cognitive function and retinal and ischemic brain changes: the Women's Health Initiative. Neurology (2012) 1.68
Application of the ABCD2 score to identify cerebrovascular causes of dizziness in the emergency department. Stroke (2012) 1.65
Recruiting subjects for acute stroke trials: a meta-analysis. Stroke (2005) 1.65
Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology (2004) 1.64
Stroke and cocaine or amphetamine use. Epidemiology (1998) 1.62
Hospitalization for congestive heart failure. Explaining racial differences. JAMA (1995) 1.58
Association between major perioperative hemorrhage and stroke or Q-wave myocardial infarction. Circulation (2012) 1.58
Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke (2009) 1.56
Imaging data reveal a higher pediatric stroke incidence than prior US estimates. Stroke (2009) 1.56
Neurological disease on the global agenda. Ann Neurol (2008) 1.56
High critical care usage due to pediatric stroke: results of a population-based study. Neurology (2012) 1.56
Financing of U.S. biomedical research and new drug approvals across therapeutic areas. PLoS One (2009) 1.55
Environmental tobacco smoke exposure as determined by cotinine in black and white young adults: the CARDIA Study. Environ Res (1993) 1.55
Socioeconomic status, race and COPD health outcomes. J Epidemiol Community Health (2009) 1.54
Inpatient statin use predicts improved ischemic stroke discharge disposition. Neurology (2012) 1.53
Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol (2010) 1.53
Recurrent hemorrhagic stroke in children: a population-based cohort study. Stroke (2007) 1.51
Hip fracture in women. Incidence, in-hospital mortality, and five-year survival probabilities in members of a prepaid health plan. Clin Orthop Relat Res (1989) 1.50
Prevalence and correlates of coronary calcification in black and white young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb Vasc Biol (2001) 1.49
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease. Eur Heart J (2009) 1.49